# Treeline Biosciences > Treeline Biosciences is a drug discovery and development company matching compelling disease targets with clinically proven drug approaches — small-molecule inhibitors, protein degraders, and antibody drug conjugates — integrating in-house R&D at U.S. and EU facilities with in silico and machine learning models. Its target-centric preclinical pipeline serves patients across oncology, immunology, and neurology. Treeline is a GV portfolio company and publishes no public developer or API surface. ## Company - [Website](https://treeline.bio/): Company homepage - [Mandate](https://treeline.bio/mandate): The company's mandate and approach - [Method](https://treeline.bio/method): How Treeline makes medicines (matchmaking, invention, integration, impact) - [Medicines](https://treeline.bio/medicines): Pipeline and programs - [Team](https://treeline.bio/team): Leadership and team - [News](https://treeline.bio/news): Company news - [Careers](https://treeline.bio/careers): Open roles - [Contact](https://treeline.bio/contact): Contact the company ## Policies - [Privacy Policy](https://treeline.bio/privacy-policy): Privacy notice - [Consumer Health Data Privacy Notice](https://treeline.bio/consumer-health-data-privacy-notice): Consumer health data privacy notice ## APIs - None published. Probes of https://treeline.bio/.well-known/* and candidate api/docs/developer subdomains found no public API, developer portal, or machine-readable discovery surface.